UK markets open in 6 hours 48 minutes

Elanco Animal Health Incorporated (ELAN)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
34.69-1.03 (-2.88%)
At close: 4:00PM EDT

Elanco Animal Health Incorporated

2500 Innovation Way
Greenfield, IN 46140
United States
877 352 6261
http://www.elanco.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full-time employees10,200

Key executives

NameTitlePayExercisedYear born
Mr. Jeffrey N. SimmonsPres, CEO & Director2.1MN/A1967
Mr. Todd S. YoungExec. VP of Corp. Governance and Strategy & CFO934.92kN/A1972
Mr. Aaron L. SchachtExec. VP of Innovation, Regulatory & Bus. Devel.955.32kN/A1968
Mr. James M. MeerVP & Chief Accounting OfficerN/AN/A1970
Mr. Chris KeeleySr. VP & Chief Information OfficerN/AN/AN/A
Mr. David S. KinardExec. VP of HR Corp. Affairs & Admin.N/AN/A1967
Ms. Tiffany Ann KanagaHead of Investor RelationsN/AN/AN/A
Ms. Jinee MajorsSr. Assistant Gen. Counsel & Assistant Corp. Sec.N/AN/AN/A
Ms. Racquel Harris MasonExec. VP & Chief Marketing OfficerN/AN/A1970
Mr. Ramiro Martin CabralExec. VP of Elanco InternationalN/AN/A1972
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as functional nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations in approximately 90 countries in North America, Europe, the Middle East, Africa, Latin America, and the Asia-Pacific. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Corporate governance

Elanco Animal Health Incorporated’s ISS governance QualityScore as of 1 June 2021 is 5. The pillar scores are Audit: 2; Board: 7; Shareholder rights: 9; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.